GA NCORP

TRIALS & PROVIDERS

Menu

NCORP Trials

Cancer Type = Head and Neck Cancer

1.
Testing Docetaxel-Cetuximab or the Addition of an Immunotherapy drug, Atezolizumab, to the Usual Chemotherapy and Radiation Therapy in High-Risk Head and Neck Cancer
Cancer Type
Head and Neck Cancer, Unknown Primary
NCI ID
NCT01810913
Protocol IDs
RTOG 1216 (primary)
NCI-2013-00500
U10CA021661
Treatment Sites (1)
 
For a complete listing of all trial sites in Georgia, please visit GeorgiaCancerInfo.org
2.
Testing Immunotherapy versus Observation in Patients with HPV Throat Cancer
Cancer Type
Head and Neck Cancer, Unknown Primary
NCI ID
NCT03811015
Protocol IDs
EA3161 (primary)
EA3161
NCI-2019-00179
Treatment Sites (4)
Nancy N. and J.C. Lewis Cancer Research Pavilion at St. Joseph Candler
Savannah
Alaina Underberg
912-819-5778
 
For a complete listing of all trial sites in Georgia, please visit GeorgiaCancerInfo.org
For a complete listing of all trials matching your criteria in Georgia, please visit GeorgiaCancerInfo.org
1-2 of 2 Trials
CALL EMAIL

Copyright © 2015, Georgia NCI Community Oncology Research Program. All Rights Reserved.
Powered by GeorgiaCancerInfo.org
Website Design & Development by Peachtree Solutions.